2.9Impact Factor
5.2CiteScore
18 daysTime to First Decision

Journal of Clinical Medicine, Volume 4, Issue 10

October 2015 - 3 articles

Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
You may sign up for email alerts to receive table of contents of newly released issues.
PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (3)

Select all

Review

24 Citations

8,722 Views

24 Pages

Nephroprotection by Hypoglycemic Agents: Do We Have Supporting Data?

Jose Luis Górriz,
Javier Nieto,
Juan F. Navarro-González,
Pablo Molina,
Alberto Martínez-Castelao and
Luis M. Pallardó

J. Clin. Med.2015, 4(10), 1866-1889;https://doi.org/10.3390/jcm4101866

23 October 2015

Current therapy directed at delaying the progression of diabetic nephropathy includes intensive glycemic and optimal blood pressure control, renin angiotensin-aldosterone system blockade and multifactorial intervention. However, the renal protection...

Full Article

Review

116 Citations

12,077 Views

18 Pages

Circulating microRNA Biomarkers as Liquid Biopsy for Cancer Patients: Pros and Cons of Current Assays

Shigeshi Ono,
Stella Lam,
Makoto Nagahara and
Dave S. B. Hoon

J. Clin. Med.2015, 4(10), 1890-1907;https://doi.org/10.3390/jcm4101890

23 October 2015

An increasing number of studies have focused on circulating microRNAs (cmiRNA) in cancer patients’ blood for their potential as minimally-invasive biomarkers. Studies have reported the utility of assessing specific miRNAs in blood as diagnostic/progn...

Full Article

Article

21 Citations

5,883 Views

13 Pages

MicroRNA Library-Based Functional Screening Identified Androgen-Sensitive miR-216a as a Player in Bicalutamide Resistance in Prostate Cancer

Toshiaki Miyazaki,
Kazuhiro Ikeda,
Wataru Sato,
Kuniko Horie-Inoue,
Koji Okamoto and
Satoshi Inoue

J. Clin. Med.2015, 4(10), 1853-1865;https://doi.org/10.3390/jcm4101853

21 October 2015

Prostate cancer is a major hormone-dependent tumor affecting men, and is often treated by hormone therapy at the primary stages. Despite its initial efficiency, the disease eventually acquires resistance, resulting in the recurrence of castration-res...

Full Article

Get Alerted

Add your email address to receive forthcoming issues of this journal.

J. Clin. Med. - ISSN 2077-0383

Imprint

Download Flyer